U.S. Markets closed

OptimizeRx: Q3 Earnings Insights

Benzinga Insights
·1 min read

Shares of OptimizeRx (NASDAQ:OPRX) were flat in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share rose 240.00% over the past year to $0.07, which beat the estimate of $0.04.

Revenue of $10,519,000 rose by 110.25% year over year, which beat the estimate of $9,770,000.

Looking Ahead

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: Nov 09, 2020

View more earnings on OPRX

Time: 04:30 PM

ET Webcast URL: https://investors.optimizerx.com/events/event-details/oprx-3rd-quarter-2020-earnings-conference-call

Price Action

Company's 52-week high was at $22.55

Company's 52-week low was at $6.50

Price action over last quarter: Up 23.90%

Company Overview

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution support patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.